Literature DB >> 4871687

Complement in human disease.

P H Schur, K F Austen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4871687     DOI: 10.1146/annurev.me.19.020168.000245

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


× No keyword cloud information.
  31 in total

1.  Immune complexes and complement hypercatabolism in patients with leprosy.

Authors:  B Bjorvatn; R S Barnetson; G Kronvall; R H Zubler; P H Lambert
Journal:  Clin Exp Immunol       Date:  1976-12       Impact factor: 4.330

Review 2.  Review: assessment of complement activation in clinical immunology laboratories: time for reappraisal?

Authors:  M Peakman; G Senaldi; D Vergani
Journal:  J Clin Pathol       Date:  1989-10       Impact factor: 3.411

3.  Complement breakdown products in plasma from patients with systemic lupus erythematosus and patients with membranoproliferative or other glomerulonephritis.

Authors:  L H Perrin; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1975-07       Impact factor: 14.808

4.  Circulating and intra-articular immune complexes in patients with rheumatoid arthritis. Correlation of 125I-Clq binding activity with clinical and biological features of the disease.

Authors:  R H Zubler; U Nydegger; L H Perrin; K Fehr; J McCormick; P H Lambert; P A Miescher
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

5.  Essential role of surface-bound complement factor H in controlling immune complex-induced arthritis.

Authors:  Nirmal K Banda; Gaurav Mehta; Viviana P Ferreira; Claudio Cortes; Matthew C Pickering; Michael K Pangburn; William P Arend; V Michael Holers
Journal:  J Immunol       Date:  2013-02-22       Impact factor: 5.422

6.  The significance of C3 and C4 complement levels in lupus nephritis.

Authors:  Y Levo; A I Pick
Journal:  Int Urol Nephrol       Date:  1974       Impact factor: 2.370

7.  Levels of serum beta 1C-beta 1A globulin (C3) and its polymorphism in leprosy patients and healthy controls from Ethiopia and Mali.

Authors:  D P Agarwal; H G Benkmann; H W Goedde; R Rohde; H Delbrück; A Rougemont
Journal:  Humangenetik       Date:  1974-03-28

8.  [Vinyl chloride disease (author's transl)].

Authors:  C E Lange; S Jühe; G Stein; G Veltman
Journal:  Int Arch Arbeitsmed       Date:  1974

9.  Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.

Authors:  C de Ceulaer; S Papazoglou; K Whaley
Journal:  Immunology       Date:  1980-09       Impact factor: 7.397

10.  Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.

Authors:  T Vijayakumar; R Ankathil; P Remani; V M Beevi; K K Vijayan; C K Panicker
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.